Jump too fast and the stomach lets you know
Other GLP-1 medications and night sweats Sweating-related reports show up across the GLP-1 class, with somewhat different patterns: Across the class, the pattern is roughly 1 to 3% of patients experience some sweating-related symptom, with night sweats being the most common subtype
Clinical research has shown it can help improve symptoms in patients with angina, reduce damage after a heart attack, and even support better circulation
With more treatment options available and accessible to patients, the more hope the medical community has for reversing the climbing overweight and obesity rates in the United States
NICE guidance recommends monitoring HbA1c levels every 36 months to assess treatment effectiveness
Temporary ALT/AST elevations occurred in a minority of participants and were generally tied to dose increases